A honokiol-enriched Magnolia officinalis Rehder & E.H. Wilson. bark extract possesses anxiolytic-like activity with neuroprotective effect through the modulation of CB1 receptor

Anxiolytic-like effects of the ethanol extract of Magnolia obovata leaves through its effects on GABA-benzodiazepine receptor and neuroinflammation

(2020) Hyeon Joo Ham et al.   BEHAVIOURAL BRAIN RESEARCH

Novel Therapeutic Approach for the Management of Mood Disorders: In Vivo and In Vitro Effect of a Combination of L-Theanine, Melissa officinalis L. and Magnolia officinalis Rehder & E.H. Wilson

(2020) Vittoria Borgonetti et al.   Nutrients

Endocannabinoid system in psychotic and mood disorders: A review of human studies

(2020) Ranjini Garani et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Involvement of HO-1 and Autophagy in the Protective Effect of Magnolol in Hepatic Steatosis-Induced NLRP3 Inflammasome Activation In Vivo and In Vitro

(2020) Ni-Chun Kuo et al.   Antioxidants

Attenuation of Anxiety-Like Behavior by Helichrysum stoechas (L.) Moench Methanolic Extract through Up-Regulation of ERK Signaling Pathways in Noradrenergic Neurons

(2020) Vittoria Borgonetti et al.   Pharmaceuticals

A review of the phytochemistry and pharmacological activities of Magnoliae officinalis cortex

(2019) Hanyan Luo et al.   JOURNAL OF ETHNOPHARMACOLOGY

Herbal medicines in the treatment of psychiatric disorders: 10-year updated review

(2018) Jerome Sarris   PHYTOTHERAPY RESEARCH

Is there a potential of misuse for Magnolia officinalis compounds/metabolites?

(2017) Fabrizio Schifano et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Brain-Derived Neurotrophic Factor, Depression, and Physical Activity: Making the Neuroplastic Connection

(2017) Cristy Phillips   NEURAL PLASTICITY

Magnolia officinalis (Hou Po) bark extract stimulates the Nrf2-pathway in hepatocytes and protects against oxidative stress

(2016) Arun Rajgopal et al.   JOURNAL OF ETHNOPHARMACOLOGY

Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP

(2015) John C McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

Herbal Medicine for Anxiety, Depression and Insomnia

(2015) Lei Liu et al.   Current Neuropharmacology

Chronic Glutamate Toxicity in Neurodegenerative Diseases—What is the Evidence?

(2015) Jan Lewerenz et al.   Frontiers in Neuroscience

Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial

(2014) Marcos Hortes N Chagas et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Neuroprotective effects of neolignans isolated from Magnoliae Cortex against glutamate-induced apoptotic stimuli in HT22 cells

(2013) Eun-Ju Yang et al.   FOOD AND CHEMICAL TOXICOLOGY

Neuro-Modulating Effects of Honokiol: A Review

(2013) Anna Woodbury et al.   Frontiers in Neurology

The natural products magnolol and honokiol are positive allosteric modulators of both synaptic and extra-synaptic GABAA receptors

(2012) Mikhail Alexeev et al.   NEUROPHARMACOLOGY

Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABAB Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission

(2012) Alejandro Aparisi Rey et al.   NEUROPSYCHOPHARMACOLOGY

Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55

(2012) Viktor Rempel et al.   ACS Medicinal Chemistry Letters

A Time-Dependent History of Mood Disorders in a Murine Model of Neuropathic Pain

(2011) Ipek Yalcin et al.   BIOLOGICAL PSYCHIATRY

Neuroprotective effects of theanine and its preventive effects on cognitive dysfunction

(2011) Takami Kakuda   PHARMACOLOGICAL RESEARCH

l-theanine protects the APP (Swedish mutation) transgenic SH-SY5Y cell against glutamate-induced excitotoxicity via inhibition of the NMDA receptor pathway

(2010) X. Di et al.   NEUROSCIENCE